A61P 25/08
Antiepileptics
Official title: Antiepileptics; Anticonvulsants
A61P25/08 (Antiepileptics) appears on 7,807 US grants and 11,197 published applications in this corpus.
Search patents in A61P- Granted patents
- 7,807
- Published applications
- 11,197
- Assignees
- 2,890
- Inventors
- 17,418
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 16 | 0 |
| 1978 | 18 | 0 |
| 1979 | 16 | 0 |
| 1980 | 22 | 0 |
| 1981 | 22 | 0 |
| 1982 | 16 | 0 |
| 1983 | 15 | 0 |
| 1984 | 16 | 0 |
| 1985 | 36 | 0 |
| 1986 | 27 | 0 |
| 1987 | 21 | 0 |
| 1988 | 19 | 0 |
| 1989 | 33 | 0 |
| 1990 | 40 | 0 |
| 1991 | 41 | 0 |
| 1992 | 32 | 0 |
| 1993 | 25 | 0 |
| 1994 | 33 | 0 |
| 1995 | 33 | 0 |
| 1996 | 44 | 0 |
| 1997 | 87 | 0 |
| 1998 | 79 | 0 |
| 1999 | 101 | 0 |
| 2000 | 101 | 0 |
| 2001 | 144 | 37 |
| 2002 | 160 | 259 |
| 2003 | 190 | 415 |
| 2004 | 177 | 593 |
| 2005 | 180 | 517 |
| 2006 | 272 | 565 |
| 2007 | 250 | 599 |
| 2008 | 264 | 605 |
| 2009 | 304 | 720 |
| 2010 | 431 | 832 |
| 2011 | 447 | 689 |
| 2012 | 438 | 704 |
| 2013 | 477 | 475 |
| 2014 | 471 | 462 |
| 2015 | 373 | 431 |
| 2016 | 307 | 399 |
| 2017 | 338 | 417 |
| 2018 | 300 | 383 |
| 2019 | 271 | 363 |
| 2020 | 257 | 344 |
| 2021 | 204 | 277 |
| 2022 | 177 | 277 |
| 2023 | 121 | 254 |
| 2024 | 129 | 225 |
| 2025 | 147 | 220 |
| 2026 | 74 | 135 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compound for the treatment and prevention of central nervous system disorders6 Oct 2026US 12,751,945 B2Abaxys Therapeutics
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Anti-galectin 3 antibodies and their use in epilepsy and related diseases6 Oct 2026US 12,752,015 B2Sunmed Therapeutic Limited
- Methods for the treatment of infantile spasms using medium chain triglycerides22 Sep 2026US 12,740,959 B2Cerecin Australia Pty Limited
- Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities22 Sep 2026US 12,740,992 B2Jazz Pharmaceuticals Research UK Limited
- Selective Serotonin Receptor Modulators and Methods of Making and Using the Same8 Oct 2026US 2026/0308110 A1Park City Bio, LLC
- Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of cns disorders8 Oct 2026US 2026/0308198 A1Sage Therapeutics, Inc.
- Antisense oligomer formulations8 Oct 2026US 2026/0308595 A1Stoke Therapeutics, Inc.
- Cannabidiol preparations and its uses1 Oct 2026US 2026/0294937 A1Jazz Pharmaceuticals Research UK Limited
- Treatment of syngap1 encephalopathy17 Sep 2026US 2026/0272957 A1Harmony Biosciences Management, Inc.
Most cited
By later US patents
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004
- Gum pad for delivery of medication to mucosal tissues1,140US 6,319,510 B12001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003